199 related articles for article (PubMed ID: 18626964)
1. Paraoxonase-1 status in Crohn's disease and ulcerative colitis.
Boehm D; Krzystek-Korpacka M; Neubauer K; Matusiewicz M; Berdowska I; Zielinski B; Paradowski L; Gamian A
Inflamm Bowel Dis; 2009 Jan; 15(1):93-9. PubMed ID: 18626964
[TBL] [Abstract][Full Text] [Related]
2. Enhanced formation of advanced oxidation protein products in IBD.
Krzystek-Korpacka M; Neubauer K; Berdowska I; Boehm D; Zielinski B; Petryszyn P; Terlecki G; Paradowski L; Gamian A
Inflamm Bowel Dis; 2008 Jun; 14(6):794-802. PubMed ID: 18213700
[TBL] [Abstract][Full Text] [Related]
3. Reduced Transferrin Levels in Active Inflammatory Bowel Disease.
Matusiewicz M; Neubauer K; Lewandowska P; Gamian A; Krzystek-Korpacka M
Biomed Res Int; 2017; 2017():9541370. PubMed ID: 29226154
[TBL] [Abstract][Full Text] [Related]
4. Lipid peroxidation markers in Crohn's disease: the associations and diagnostic value.
Boehm D; Krzystek-Korpacka M; Neubauer K; Matusiewicz M; Paradowski L; Gamian A
Clin Chem Lab Med; 2012 Mar; 50(8):1359-66. PubMed ID: 22868800
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
6. The insulin-like growth factor system and markers of inflammation in adult patients with inflammatory bowel disease.
Eivindson M; Nielsen JN; Grønbaek H; Flyvbjerg A; Hey H
Horm Res; 2005; 64(1):9-15. PubMed ID: 16088202
[TBL] [Abstract][Full Text] [Related]
7. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
[TBL] [Abstract][Full Text] [Related]
8. Circulating midkine in Crohn's disease: clinical implications.
Krzystek-Korpacka M; Neubauer K; Matusiewicz M
Inflamm Bowel Dis; 2010 Feb; 16(2):208-15. PubMed ID: 19572374
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of circulating midkine in ulcerative colitis.
Krzystek-Korpacka M; Neubauer K; Matusiewicz M
Clin Chem Lab Med; 2009; 47(9):1085-90. PubMed ID: 19728850
[TBL] [Abstract][Full Text] [Related]
10. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
[TBL] [Abstract][Full Text] [Related]
11. Faecal elastase reflects disease activity in active ulcerative colitis.
Adeyemi EO; Hodgson HJ
Scand J Gastroenterol; 1992; 27(2):139-42. PubMed ID: 1561528
[TBL] [Abstract][Full Text] [Related]
12. Increased circulating circular RNA_103516 is a novel biomarker for inflammatory bowel disease in adult patients.
Ye YL; Yin J; Hu T; Zhang LP; Wu LY; Pang Z
World J Gastroenterol; 2019 Nov; 25(41):6273-6288. PubMed ID: 31749597
[TBL] [Abstract][Full Text] [Related]
13. Correlation of Paraoxonase-1 with the Severity of Crohn's Disease.
Szczeklik K; Mach T; Cibor D; Owczarek D; Sapa J; Papież M; Pytko-Polończyk J; Krzyściak W
Molecules; 2018 Oct; 23(10):. PubMed ID: 30314292
[TBL] [Abstract][Full Text] [Related]
14. Platelet/Albumin ratio and plateletcrit levels are potential new biomarkers for assessing endoscopic inflammatory bowel disease severity.
Huang J; Lu J; Jiang F; Song T
BMC Gastroenterol; 2023 Nov; 23(1):393. PubMed ID: 37964205
[TBL] [Abstract][Full Text] [Related]
15. Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes.
Schoepfer AM; Beglinger C; Straumann A; Safroneeva E; Romero Y; Armstrong D; Schmidt C; Trummler M; Pittet V; Vavricka SR
Inflamm Bowel Dis; 2013 Feb; 19(2):332-41. PubMed ID: 23328771
[TBL] [Abstract][Full Text] [Related]
16. Association between red cell distribution width and disease activity in patients with inflammatory bowel disease.
Song CS; Park DI; Yoon MY; Seok HS; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI
Dig Dis Sci; 2012 Apr; 57(4):1033-8. PubMed ID: 22147246
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-9: its interplay with angiogenic factors in inflammatory bowel diseases.
Matusiewicz M; Neubauer K; Mierzchala-Pasierb M; Gamian A; Krzystek-Korpacka M
Dis Markers; 2014; 2014():643645. PubMed ID: 24803722
[TBL] [Abstract][Full Text] [Related]
18. Laboratory values in Japanese children with newly diagnosed inflammatory bowel disease.
Takaki Y; Mizuochi T; Eda K; Ishihara J; Yamashita Y
Pediatr Int; 2019 Jul; 61(7):720-725. PubMed ID: 31102555
[TBL] [Abstract][Full Text] [Related]
19. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
Nancey S; Boschetti G; Moussata D; Cotte E; Peyras J; Cuerq C; Haybrard J; Charlois AL; Mialon A; Chauvenet M; Stroeymeyt K; Kaiserlian D; Drai J; Flourié B
Inflamm Bowel Dis; 2013 Apr; 19(5):1043-52. PubMed ID: 23511035
[TBL] [Abstract][Full Text] [Related]
20. Impaired erythrocyte antioxidant defense in active inflammatory bowel disease: impact of anemia and treatment.
Krzystek-Korpacka M; Neubauer K; Berdowska I; Zielinski B; Paradowski L; Gamian A
Inflamm Bowel Dis; 2010 Sep; 16(9):1467-75. PubMed ID: 20186929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
